Dr. William Evans graduated from the University of Leeds MBChB in 2002. After surgical training, gaining MRCS in 2007, he changed his career to general practice, qualifying as a GP with MRCGP in 2010. He completed a Post-Graduate Certificate in Education in Primary Care with Merit from the University of Leeds in 2013 and an MSc in Genomic Medicine with distinction from the University of Manchester in 2018. He currently works clinically as a part-time salaried GP in Leeds and as a GPwSI in Clinical Genetics with the Yorkshire Regional Genetic Service. He has an academic position with the Primary Care Stratified Medicine group at the University of Nottingham. He currently holds an NIHR GP Career Progression fellowship award. He is also a trustee of a national rare disease charity, NPUK. His research interests include rare disease, mainstreaming genomic technologies and the role of primary care, and precision medicine.

Prof. Eric M. Meslin is the President and CEO of the Council of Canadian Academies (CCA). He joined the CCA in 2016 after 25 years in university and government settings, including the previous 15 years at Indiana University where he was Founding Director of the IU Center for Bioethics, Associate Dean for Bioethics in the IU School of Medicine, and Professor of Medicine, of Philosophy, of Medical and Molecular Genetics, of Bioethics and Law, and of Public Health. Trained in bioethics and philosophy at York University (BA) and Georgetown University (MA, PhD), he has held academic positions at the University of Toronto, University of Oxford, Sunnybrook Health Sciences Centre, University of Western Australia, and Université de Toulouse. He is Adjunct Professor at the Dalla Lana School of Public Health, University of Toronto; Senior Fellow at the PHG Foundation University of Cambridge; and 2020–2023 Mentor for the Pierre Elliot Trudeau Foundation. His policy experience includes Bioethics Research Director in the Ethical, Legal and Social Implications (ELSI) program at the National Human Genome Research Institute and Executive Director of the National Bioethics Advisory Commission appointed by President Clinton. He has been a member of advisory committees to the World Health Organization, UNESCO, the Canadian Institutes of Health Research, the Institute of Medicine, UK Biobank, CDC, and Genome Canada.

Prof. Joe Kai has been an inner-city general practitioner since 1991 and a Professor of Primary Care at Nottingham since 2003. He was Founding Chair and Head of Primary Care leading teaching at the new Graduate Entry Medical School (2003-2010) before becoming Head of Primary Care in the School of Medicine (2012 to August 2020). The Division of Primary Care delivers internationally excellent research and the teaching and training of medical students across all five years of the BMBS course at Nottingham. He has led Nottingham in its third successful application to be part of the National Institute for Health Research (NIHR) School for Primary Care. The most recent five-year programme (2021-2026) is a partnership between the country's leading primary care units to enhance research capacity and deliver high-quality research evidence for primary care. His research focuses on primary care stratified medicine; applied genetics in primary care—use of family history; common inherited problems such as haemoglobin disorders and familial hypercholesteroalemia; reducing inequality and responding to ethnic diversity in health and health care; women's health care; using trials, qualitative, and community participatory methods, etc.

Prof. Dr. Nadeem Qureshi qualified from University College London Medical School in 1986. He achieved his MSc in Health Service Research with Distinction in 1999 and completed a Doctorate in 2006. Between 2004 and 2005, he was awarded a US Harkness fellowship in Genetics at the CDC. In 2011, he was appointed as Clinical Professor at University of Nottingham. His research focuses on translating genomic medicine into non-specialist healthcare settings. This includes a portfolio of health service research on cardiovascular and cancer genetics. This research aligns with emerging screening policies and related national clinical guidelines He is currently a member of the Genomics England Ethics Advisory Committee. He has been a primary care representative in the English NICE guideline development groups for familial hypercholesterolaemia, lipid modification and familial breast cancer. He has also recently been appointed as a Fellow of the Faculty of Clinical Informatics for his primary care database research.